Kallmann's syndrome is a rare disorder characterized by hypogonadotropic hypogonadism with anosmia and a wide variety of dysmorphic features including midline and somatic defects. It is thought to be an inherited condition, both X-linked' and autosomal inheritance2 having been implicated. Ulcerative colitis is a common disorder in which there is evidence of an hereditary component, 29% of patients in one recent series having a positive family history3. Demonstration ofthe association between ulcerative colitis and hereditary conditions may therefore contribute to an understanding of the aetiology of inflammatory bowel disease.
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Case report
Aged 19, the patient presented with a fractured neck of femur, following a fall. He was noted then to be tall and hypogonadal. A diagnosis of eunochoid gigantism was made and replacement therapy with testosterone implants commenced. Nine years later he presented with a short history of passing blood and mucus per rectum. A diagnosis of ulcerative colitis was made and he was treated effectively with steroid enemata. He went into remission and received no further treatment for colitis for 34 years. During this period he received regular testosterone replacement, initially as implants and later by injection, and developed secondary sexual characteristics. Aged 40 he was referred to Northwick Park Hospital, at which time it was noted that he had dysmorphic features, anosmia and impalpable testes. There was no family history of either abnormal morphological features, anosmia or bowel disease. At this time he had no bowel symptoms. Eight years later he developed a left groin swelling and, at surgery, a small soft testis was removed. Subsequently his right groin was explored and further testicular tissue removed prophylactically. He remained well until December 1984 (aged 53 years) when he had a recurrence of bloody diarrhoea associated with weight loss and flatulent dyspepsia. On examination he was 1.81 m tall, with the following dysmorphic features: dolichostenomelia (arm span 1.87 m), cubitus valgus, a high arched palate, left sternocleidomontoid dysgenesis, left hemi-facial atrophy, kyphosis and a deformed left ear. Examination revealed abdominal wall scars from testosterone implantation: the abdomen was otherwise normal. Cranial nerve examination showed complete anosmia, signs of old choroidoretinitis and sensori-neural deafness.
Sigmoidoscopy to 150mm revealed a granular mucosa with contact bleeding. Histology of rectal biopsies demonstrated features characteristic of chronic ulcerative colitis with numerous lymphoid follicles, a diffuse chronic inflammatory infiltrate and prominent glandular atrophy and distortion. Stool culture was negative and barium enema showed a rather featureless colon with a finely granular mucosa. Barium meal and follow-through examinations demonstrated a moderate-sized sliding hiatus hernia with no evidence of reflux. The terminal ileum appeared normal. Biochemical and haematological indices were normal. Small bowel permeability was assessed, on two occasions whilst in remission by measuring urinary excretion of Cr51EDTA: 6.7 and 5.5% of the oral dose was excreted, normals excreting less than 3%4.
Endocrine investigation three weeks after his last implant revealed a testosterone level of 18 nmol/l (reference range 10-30 nmol/1). Baseline levels of both luteinizing hormone and follicle stimulating hormone were below the range of the assay and failed to respond to 100,Ag luteinizing hormone releasing hormone intravenously; thus confirming hypogonadotropic hypogonadism. Other standard tests ofhypothalamic-pituitary axis function including intravenous insulin tolerance and thyrotropin releasing hormone tests were normal. Examination of his chromosomes revealed no abnormalities.
Treatment was commenced with sulphasalazine 500 mg four times daily and regular antacids. On this regime his bowel symptoms have improved significantly. He continues to receive monthly testosterone injections.
Discussion
Kallmann's syndrome has been associated with many structural disorders including renal', cardiac5 and intracranial abnormalities6. Lieblich et aL7 recently reported the clinical features of a series of 23 cases including one with associated malrotation of the gut. To our knowledge the association with inflammatory bowel disease has not been previously reported.
The association of inflammatory bowel disease with chromosome abnormalities, particularly those affecting the X-chromosome, may be of aetiological significance. Unfortunately in the absence of a suitable family history it is not possible to determine whether the present patient conforms to the X-linked variety. In particular, it is possible that it is the hypogonadism of these conditions which predisposes to inflammatory bowel disease.
The Turner syndrome, another condition in which somatic defects and hypogonadism co-exist has been reported to be associated with inflammatory bowel disease. Williams8 described a 24-year-old patient with XO mosaicism and severe ulcerative Case presented to Clinical Section, 11 April 1986 colitis requiring colectomy. Price9 provided further evidence of such an association, commenting on the unexpectedly high incidence of both Crohn's disease and ulcerative colitis in 135 patients with the Turner syndrome, of whom 4 developed inflammatory bowel disease over an 11 year period.
The increased intestinal permeability in the presence of normal small bowel radiology is of interest. Mild ulcerative colitis is usually associated with normal permeability4 and the increase may reflect a genetic diathesis to inflammatory bowel disease. Further studies are necessary to investigate this point. (Table 1) with low basal and suboptimal poststimulatory gonadotropin levels, consistent with hypogonadotropic hypogonadism. He received a 4 week subcutaneous pulsatile luteinizing hormone releasing hormone (LHRH) infusion (2.5 tg/pulse) which resulted in a rise in LH but not folliclestimulating hormone (FSH). Testosterone levels failed to rise following firstly human chorionic gonadotrophin (HCG) and then during the LHRH infusion; this may reflect dysplasia of the Leydig tissue associated with the cryptorchidism. The growth hormone responses to dynamic testing were suboptimal probably due to his gross obesity, but other pituitary hormone responses were normal.
CT scanning and later a nuclear magnetic resonance scan detailed agenesis of the corpus callosum and anterior commissure with abnormalities of the temporal lobes and hippocampus. A Dandy-Walker cystic malformation lay within the posterior fossa, communicating with a slightly enlarged 4th ventricle, and associated with an absent inferior vermis of the 
